Drill Research LLC (“Drill Research”) is the subsidiary and research arm of Drill Capital LLC. Drill Research is an energy research platform that gives investors access to the proprietary process that informs our investment arm Drill Capital on capital allocation decisions within the energy sector.
Drill Capital LLC (“Drill”) is an alternative investment firm committed to delivering attractive risk-adjusted returns to clients by investing exclusively in assets related to the growing North American energy industry. We invest across a variety of asset classes, including real estate and infrastructure, in order to capitalize on shifts in the market while protecting capital.
Drill was founded by Farid Guindo, a former energy analyst at Ospraie Management and Barclays Capital. Drill targets non traditional opportunistic private and public investments that offer exposure to the energy markets in North America. We believe this targeted approach best harnesses our expertise for the benefit of our clients across the globe.
Drill creates returns by leveraging a unique research platform that spans the entire energy value chain. This platform relies on deep fundamental research within the energy space involving significant due diligence processes and risk mitigation. We focus on compounding gains over the long term, regardless of the prevailing investment environment.
All information provided is for informational purposes only and should not be deemed as investment advice or a recommendation.
Drill Research or any of their subsidiaries or affiliates, nor any of their respective officers, directors, employees or agents, accepts any liability whatsoever for any direct, indirect or consequential losses (in contract, tort or otherwise) arising from the use of this document or its contents or reliance on the information contained herein.
The information in this document has not been independently verified by Drill Research. Drill Research or any of its subsidiaries or affiliates, nor any of their respective directors, officers, employees or agents, makes any warranty or representation, express or implied, as to the accuracy or completeness of the information which is contained in this document whether obtained from or based upon third party or public sources or otherwise. Drill Research does not undertake any obligation to provide any additional information or to update any of the information or the conclusions contained herein or to correct any inaccuracies which may become apparent. Past performance is no guarantee of future returns.
Earned a Doctorate in Pharmacy (Pharm.D.) in 2010 and Pre-Pharmacy/B.S. in Molecular Biology in 2006. Over six years of direct experience in translational research in oncology investigating the molecular/cellular mechanisms of carcinogenesis focused on biomarker identification and validation working in a multi-disciplinary matrix environment across academia, contract research organizations and industry.
Analyst Tip Ranks: https://www.tipranks.com/experts/dr.-paul-nunzio-desantis%252C-pharm.d